Doxycycline calcium

多西环素钙

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameDoxycycline calcium
Drug Alias NameCalcii Doxycyclinum多西环素钙盐Doxyc ycline CalciqueVibramycin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsMatrix metalloproteinase inhibitors
Targets30S ribosomal subunitMatrix metalloproteinase
Therapy Area/IndicationsLymphomaBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1974/09/23
Country/TerritoryUnited StatesEgypt
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCairo UniversityPfizer Inc
Active IndicationsN/A
Inactive IndicationsLymphomaBacterial Infections

Other Information

ATC CodeA01AB22J01AA02
Related LinksWikipediaDrugBankKEGG